Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer

Expert Review of Molecular Diagnostics

Volumn 6, Issue 1, 2006, Pages 39-50

  Zhou, Xiaofeng ^a   Yu, Tianwei ^b   Cole, Steven W ^c   Wong, David T W ^c  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comparative genomic; Hybridization; Loss of heterozygosity; Multicolor fluorescence in situ hybridization; Personalized therapies; Single nucleotide polymorphism array; Spectral karyotyping; Tiling array

Indexed keywords

DNA;

ALLELIC IMBALANCE; CANCER DIAGNOSIS; CANCER THERAPY; CHROMOSOME ABERRATION; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; MUTATION; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PROGNOSIS; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION;

EID: 33645377519     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.1.39     Document Type: Review

References (97)

1. Liehr T, Heller A, Starke H, Claussen U. FISH banding methods: applications in research and diagnostics. Expert Rev. Mol. Diagn. 2(3), 217-225 (2002). Good review on fluorescence in situ hybridization.
2. Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J. Natl Cancer Inst. 25, 85-109 (1960).
3. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 409(6822), 860-921 (2001).
4. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 291(5507), 1304-1351 (2001).
5. Schwaenen C, Nessling M, Wessendorf S et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc. Natl Acad. Sci. USA 101(4), 1039-1044 (2004).
6. Paris PL, Andaya A, Fridlyand J et al. Whole-genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum. Mol. Genet. 13(13), 1303-1313 (2004).
7. Callagy G, Pharoah P, Chin SF et al. Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J. Pathol. 205(3), 388-396 (2005).
8. Weiss MM, Kuipers EJ, Postma C et al. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol. 26(5-6), 307-317 (2004).
9. Rosin MP, Cheng X, Poh C et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin. Cancer Res. 6(2), 357-362 (2000).
10. Martinez-Climent JA, Alizadeh AA, Segraves R et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 101(8), 3109-3117 (2003).
11. Rubio-Moscardo F, Climent J, Siebert R et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 105(11), 4445-4454 (2005).
12. Mundle SD, Sokolova I. Clinical implications of advanced molecular cytogenetics in cancer. Expert Rev. Mol. Diagn. 4(1), 71-81 (2004). Review on genomic discoveries and cancer.
13. Futreal PA, Coin L, Marshall M et al. A census of human cancer genes. Nature Rev. Cancer 4(3), 177-183 (2004). Latest summary of cancer-related genes.
14. Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics. Am. J. Respir. Cell. Mol. Biol. 32(3), 169-176 (2005).
15. Jeffrey SS, Lonning PE, Hillner BE. Genomics-based prognosis and therapeutic prediction in breast cancer. J. Natl Compr. Canc. Netw. 3(3), 291-300 (2005).
16. Avivi I, Rowe JM. Prognostic factors in acute myeloid leukemia. Curr. Opin. Hematol. 12(1), 62-67 (2005).
17. Wang TL, Maierhofer C, Speicher MR et al. Digital karyotyping. Proc. Natl Acad. Sci. USA 99(25), 16156-16161 (2002).
18. Imoto H, Hirotsune S, Muramatsu M et al. Direct determination of NotI cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning. DNA Res. 1(5), 239-43 (1994).
19. Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 259(5097), 946-951 (1993).
20. Crawley JJ, Furge KA. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol. 3(12), RESEARCH0075 (2002).
21. Zhou X, Cole SW, Chen Z, Li Y, Wong DT. Identification of discrete chromosomal deletion by binary recursive partitioning of microarray differential expression data. J. Med. Genet. 42(5), 416-419 (2005).
22. Zhou X, Cole SW, Hu S, Wong DT. Detection of DNA copy number abnormality by microarray expression analysis. Hum. Genet. 114(5), 464-467 (2004).
23. Kallioniemi A, Kallioniemi OP, Sudar D et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258(5083), 818-821 (1992).
24. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nature Genet. 37(Suppl.), S11-S17 (2005). Good review on comparative genomic hybridization (CGH).
25. Pinkel D, Albertson DG. Comparative genomic hybridization. Ann. Rev. Genomics Hum. Genet. 6, 331-354 (2005).
26. Pinkel D, Segraves R, Sudar D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 20(2), 207-211 (1998).
27. Ishkanian, AS, Malloff CA, Watson SK et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nature Genet. 36(3), 299-303 (2004).
28. Mantripragada KK, Buckley PG, de Stahl TD, Dumanski JP. Genomic microarrays in the spotlight. Trends Genet. 20(2), 87-94 (2004).
29. Pollack JR, Perou CM, Alizadeh AA et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23(1), 41-46 (1999).
30. Zhou X, Jordan RCK, Mok S, Birrer MJ, Wong DT. DNA copy number abnormality of oral squamous cell carcinoma detected by cDNA array-based CGH. Cancer Genet. Cytogen. 151(1), 90-92 (2004).
31. Brennan C, Zhang Y, Leo C et al. High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res. 64(14), 4744-4748 (2004).
32. Lucito R, Healy J, Alexander J et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res. 13(10), 2291-2305 (2003).
33. Bignell GR, Huang J, Greshock J et al. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res. 14(2), 287-295 (2004).
34. Zhao X, Li C, Paez JG et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 64(9), 3060-3071 (2004). Concurrent loss-of-heterozygosity (LOH) and CGH analysis using single nucleotide polymorphism (SNP) arrays.
35. Zhou X, Mok SC, Chen Z, Li Y, Wong DT. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array. Hum. Genet. 115(4), 327-330 (2004). Concurrent LOH and CGH analysis using SNP arrays.
36. Zhao X, Weir BA, LaFramboise T et al. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res. 65(13), 5561-70 (2005).
37. Davies JJ, Wilson IM, Lam WL. Array CGH technologies and their applications to cancer genomes. Chromosome Res. 13(3), 237-248 (2005).
38. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 270(5235), 484-487 (1995).
39. Shihle M, Sheu JJ, Santillan A et al. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc. Natl Acad. Sci. USA 102(39), 14004-14009 (2005).
40. Di C, Liao S, Adamson DC et al. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res. 65(3), 919-924 (2005).
41. Wang TL, Diaz LA Jr, Romans K et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc. Natl Acad. Sci. USA 101(9), 3089-3094 (2004).
42. Parrett TJ, Yan H. Digital karyotyping technology: exploring the cancer genome. Expert Rev. Mol. Diagn. 5(6), 917-25 (2005). Good review on digital karyotyping.
43. Shih Ie M, Wang TL. Apply innovative technologies to explore cancer genome. Curr. Opin. Oncol. 17(1), 33-38 (2005).
44. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68(4), 820-823 (1971).
45. Knudson AG. Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol. 122(3), 135-140 (1996).
46. Friend SH, Bernards R, Rogelj S et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643-646 (1986).
47. Vogelstein B, Fearon ER, Kern SE et al. Alleotype of colorectal carcinomas. Science 244, 201-211 (1989).
48. Wang DG, Fan JB, Siao CJ et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280(5366), 1077-1082 (1998).
49. Lindblad-Toh K, Tanenbaum DM, Daly MJ et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nature Biotechnol. 18(9), 1001-1005 (2000).
50. Janne PA, Li C, Zhao X et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene 23(15), 2716-2726 (2004).
51. Wang ZC, Lin M, Wei LJ et al. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res. 64(1), 64-71 (2004).
52. Hoque MO, Lee CC, Cairns P, Schoenberg M, Sidransky D. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res. 63(9), 2216-2222 (2003).
53. Lieberfarb ME, Lin M, Lechpammer M et al. Genome-wide loss of heterozygosity analysis from laser-capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res. 63(16), 4781-4785 (2003).
54. Zhou X, Li C, Mok SC, Chen Z, Wong DTW. Whole-genome loss of heterozygosity profiling on oral squamous cell carcinoma by high-density single nucleotide polymorphic allele (SNP) array. Cancer Genet. Cytogenet. 151(1), 82-84 (2004).
55. Huang J, Wei W, Zhang J et al. Whole-genome DNA copy number changes identified by high-density oligonucleotide arrays. Hum. Genomics 1(4), 287-299 (2004).
56. Caspersson T, Zech L, Modest EJ, Foley GE, Wagh U, Simonsson E. Chemical differentiation with fluorescent alkylating agents in Vicia faba metaphase chromosomes. Exp. Cell Res. 58(1), 128-140 (1969).
57. Caspersson T, Zech L, Modest EJ, Foley GE, Wagh U, Simonsson E. DNA-binding fluorochromes for the study of the organization of the metaphase nucleus. Exp. Cell Res. 58(1), 141-152 (1969).
58. Schrock E, du Manoir S, Veldman T et al. Multicolor spectral karyotyping of human chromosomes. Science 273(5274), 494-497 (1996).
59. Liyanage M, Coleman A, du Manoir S et al. Multicolour spectral karyotyping of mouse chromosomes. Nature Genet. 14(3), 312-315 (1996).
60. Speicher MR, Gwyn Ballard S, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genet. 12(4), 368-375 (1996).
61. Liu AY, Brubaker KD, Goo YA et al. Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines. Prostate 60(2), 98-108 (2004).
62. International System for Human Cytogenetic Nomenclature. Guidelines for cancer cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Mitelman F (Ed.), Karger, Switzerland (1995).
63. Weir B, Zhao X, Meyerson M. Somatic alterations in the human cancer genome. Cancer Cell 6(5), 433-438 (2004).
64. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nature Genet. 34(4), 369-76 (2003). Comprehensive review in cancer genomics.
65. Vogelstein B, Kinzler KW. The Genetic Basis of Human Cancer. McGraw-Hill, Toronto, Canada, (2002).
66. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature Med. 10(8), 789-799 (2004).
67. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286(5439), 531-537 (1999).
68. Ohyama H, Mahadevappa M, Luukkaa H, Todd R, Warrington J, Wong DT. Use of LCM-generated targets for hybridization of high-density oligonucleotide arrays. In: Methods in Enzymology. Conn PM (Ed.), 356, 323-333 (2002).
69. Ohyama H, Zhang X, Kohno Y et al. Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization. Biotechniques 29(3), 530-536 (2000).
70. Simone NL, Remaley AT, Charboneau L et al. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am. J. Pathol. 156(2), 445-452 (2000).
71. Zhou X, Teman S, Chen Z, Ye H, Mao L, Wong DT. Allelic imbalance analysis of oral tongue cancer by high-density single nucleotide polymorphism arrays using whole-genome-amplified DNA. Hum. Genet. (2005) (In Press).
72. Dean FB, Hosono S, Fang L et al. Comprehensive human genome amplification using multiple displacement amplification. Proc. Natl Acad. Sci. USA 99(8), 5261-5266 (2002).
73. Paez JG, Lin M, Beroukhim R et al. Genome coverage and sequence fidelity of φ29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 32(9), e71 (2004).
74. Pettenati MJ, Jackle B, Bobby P et al. Unexpected retention and concomitant loss of subtelometic regions in balanced chromosome anomalies by FISH. Am. J. Med. Genet. 111(1), 48-53 (2002).
75. Myers CL, Dunham MJ, Kung SY, Troyanskaya OG. Accurate detection of aneuploidies in array CGH and gene expression microarray data. Bioinformatics 20(18), 3533-3543 (2004).
76. Pollack JR, Sorlie T, Perou CM et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl Acad. Sci. USA 99(20), 12963-12968 (2002).
77. Wolf M, Mousses S, Hautaniemi S et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 6(3), 240-247 (2004).
78. Kauraniemi P, Kuukasjarvi T, Sauter G, Kallioniemi A. Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. Am. J. Pathol. 163(5), 1979-1984 (2003).
79. Phillips JL, Hayward SW, Wang Y et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res. 61(22), 8143-8149 (2001).
80. Virtaneva K, Wright FA, Tanner SM et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc. Natl Acad. Sci. USA 98(3), 1124-1129 (2001).
81. Cole SW, Yan W, Galic Z, Arevalo J, Zack JA. Expression-based monitoring of transcription factor activity: the TELiS database. Bioinformatics 21(6), 803-810 (2005).
82. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, Weng Z. Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 32(4), 1372-1381 (2004).
83. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(5235), 467-470 (1995).
84. Autio R, Hautaniemi S, Kauraniemi P et al. CGH-Plotter: MATLAB toolbox for CGH-data analysis. Bioinformatics 19(13), 1714-1715 (2003).
85. Eilers PHC, de RX Menezes. Quantile smoothing of array CGH data. Bioinformatics 21(7), 1146-1153 (2005).
86. Fridlyand J, Snijders AM, Pinkel D, Albertson DG, Jain AN. Hidden Markov models approach to the analysis of array CGH data. J Multivariate Anal. 90(1), 132-153 (2004).
87. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20(8), 1233-1240 (2004). Useful tool for concurrent LOH and CGH analyses using SNP array.
88. Armstrong NJ, van de Wiel MA. Microarray data analysis: from hypotheses to conclusions using gene expression data. Cell Oncol. 26(5-6), 279-290 (2004).
89. Dudoit S, Fridlyand J, Speed T. Comparison of discrimination methods for the classification of tumors using gene expression data. J. Am. Stat. Assoc, 97, 77-87 (2002).
90. Massion PP, Kuo WL, Stokoe D et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: Implications of the phosphatidylinositol 3-kinase pathway. Cancer Res. 62(13), 3636-3640 (2002).
91. Veltman JA, Fridlyand J, Pejavar S et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 63(11), 2872-2880 (2003).
92. Gordon GJ, Rockwell GN, Godfrey PA et al. Validation of genomics-based prognostic tests in malignant pleura mesothelioma. Clin. Cancer Res. 11(12), 4406-4414 (2005).
93. Lipson D, Ben-Dor A, Dehan E, Yakhini Z. Joint analysis of DNA copy numbers and gene expression levels. Algorithms in Bioinformatics, Proceedings 3240, 135-146 (2004).
94. Smid M, Dorssers LCJ. GO-Mapper: functional analysis of gene expression data using the expression level as a score to evaluate gene ontology terms. Bioinformatics 20(16), 2618-2625 (2004).
95. Volinia S, Evangelisti R, Francioso F, Arcelli D, Carella M, Gasparini P. GOAL: automated gene ontology analysis of expression profiles. Nucl. Acids Res. 32, W492-W499 (2004).
96. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio - the analysis and navigation of molecular networks. Bioinformatics 19(16), 2155-2157 (2003).
97. Rzhetsky A, Iossifov I, Koike T et al. GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J. Biomed. Inform. 37(1), 43-53 (2004).